|
ICU Medical, Inc. (ICUI) DCF -Bewertung
US | Healthcare | Medical - Instruments & Supplies | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
ICU Medical, Inc. (ICUI) Bundle
Erwerben Sie die Kontrolle über Ihre ICUI -Bewertungsanalyse für ICU Medical, Inc. (ICUI) mit unserem ausgefeilten DCF -Taschenrechner! Diese Excel -Vorlage wird mit realen ICUI -Daten vorinstalliert, sodass Sie Prognosen und Annahmen anpassen können, um den inneren Wert von ICU Medical, Inc. genau zu bestimmen.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,271.0 | 1,316.3 | 2,280.0 | 2,259.1 | 2,382.0 | 2,866.2 | 3,448.8 | 4,149.8 | 4,993.2 | 6,008.1 |
| Revenue Growth, % | 0 | 3.56 | 73.21 | -0.9154 | 5.44 | 20.33 | 20.33 | 20.33 | 20.33 | 20.33 |
| EBITDA | 194.1 | 223.5 | 191.5 | 253.2 | 43.0 | 307.6 | 370.1 | 445.4 | 535.9 | 644.8 |
| EBITDA, % | 15.27 | 16.98 | 8.4 | 11.21 | 1.8 | 10.73 | 10.73 | 10.73 | 10.73 | 10.73 |
| Depreciation | 94.8 | 99.3 | 258.8 | 228.8 | .0 | 209.1 | 251.6 | 302.8 | 364.3 | 438.4 |
| Depreciation, % | 7.46 | 7.54 | 11.35 | 10.13 | 0 | 7.3 | 7.3 | 7.3 | 7.3 | 7.3 |
| EBIT | 99.2 | 124.2 | -67.3 | 24.4 | 43.0 | 98.5 | 118.5 | 142.6 | 171.5 | 206.4 |
| EBIT, % | 7.81 | 9.43 | -2.95 | 1.08 | 1.8 | 3.44 | 3.44 | 3.44 | 3.44 | 3.44 |
| Total Cash | 410.8 | 567.2 | 213.0 | 254.7 | 308.6 | 624.7 | 751.7 | 904.5 | 1,088.4 | 1,309.6 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 124.1 | 105.9 | 221.7 | 182.1 | 202.7 | 252.8 | 304.2 | 366.0 | 440.4 | 530.0 |
| Account Receivables, % | 9.76 | 8.04 | 9.72 | 8.06 | 8.51 | 8.82 | 8.82 | 8.82 | 8.82 | 8.82 |
| Inventories | 314.9 | 290.2 | 696.0 | 709.4 | 584.7 | 764.1 | 919.4 | 1,106.3 | 1,331.2 | 1,601.7 |
| Inventories, % | 24.78 | 22.05 | 30.53 | 31.4 | 24.55 | 26.66 | 26.66 | 26.66 | 26.66 | 26.66 |
| Accounts Payable | 71.9 | 81.1 | 215.9 | 150.0 | 148.0 | 195.7 | 235.5 | 283.4 | 341.0 | 410.3 |
| Accounts Payable, % | 5.65 | 6.16 | 9.47 | 6.64 | 6.21 | 6.83 | 6.83 | 6.83 | 6.83 | 6.83 |
| Capital Expenditure | -100.4 | -81.2 | -99.3 | -93.7 | -79.4 | -148.5 | -178.6 | -215.0 | -258.6 | -311.2 |
| Capital Expenditure, % | -7.9 | -6.17 | -4.36 | -4.15 | -3.33 | -5.18 | -5.18 | -5.18 | -5.18 | -5.18 |
| Tax Rate, % | -78.28 | -78.28 | -78.28 | -78.28 | -78.28 | -78.28 | -78.28 | -78.28 | -78.28 | -78.28 |
| EBITAT | 88.4 | 104.0 | -43.7 | 9.3 | 76.6 | 74.0 | 89.0 | 107.1 | 128.9 | 155.1 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -284.3 | 174.2 | -271.0 | 104.7 | 99.3 | -47.2 | -4.9 | -5.9 | -7.1 | -8.6 |
| WACC, % | 6.72 | 6.61 | 6.22 | 5.66 | 6.94 | 6.43 | 6.43 | 6.43 | 6.43 | 6.43 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -65.4 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | -9 | |||||||||
| Terminal Value | -367 | |||||||||
| Present Terminal Value | -268 | |||||||||
| Enterprise Value | -334 | |||||||||
| Net Debt | 1,274 | |||||||||
| Equity Value | -1,608 | |||||||||
| Diluted Shares Outstanding, MM | 24 | |||||||||
| Equity Value Per Share | -65.94 |
What You Will Get
- Comprehensive Financial Model: ICU Medical’s actual data facilitates accurate DCF valuation.
- Complete Forecast Flexibility: Modify revenue growth, profit margins, WACC, and other critical factors.
- Real-Time Calculations: Instant updates ensure you view results as you adjust inputs.
- Professional-Grade Template: A polished Excel file crafted for high-quality valuation.
- Adaptable and Reusable: Designed for versatility, allowing frequent use for in-depth forecasts.
Key Features
- 🔍 Real-Life ICUI Financials: Pre-filled historical and projected data for ICU Medical, Inc. (ICUI).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) such as WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate ICU Medical’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize ICU Medical’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered ICU Medical data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for ICU Medical’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for ICU Medical, Inc. (ICUI)?
- Accurate Data: Utilizes real ICU Medical financials to provide dependable valuation outcomes.
- Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Pre-configured calculations save you the hassle of building from the ground up.
- Professional-Grade Tool: Tailored for investors, analysts, and consultants in the healthcare sector.
- User-Friendly: Features an intuitive design and step-by-step guidance for users of all experience levels.
Who Should Use This Product?
- Healthcare Professionals: Understand the latest innovations in IV therapy and their applications in patient care.
- Medical Researchers: Utilize data from ICU Medical, Inc. (ICUI) to enhance studies on infusion technologies.
- Investors: Evaluate market trends and assess the financial performance of ICU Medical, Inc. (ICUI).
- Healthcare Administrators: Streamline operational efficiencies with integrated infusion solutions.
- Clinical Educators: Incorporate advanced infusion practices into training programs for medical staff.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled ICU Medical historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for ICU Medical, Inc. (ICUI).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.